Facing Cancer Drug Shortage, U.S. Relies on Banned Chinese Plant

Last September, U.S. regulators faced a dilemma: whether to allow importation of drug ingredients from a Chinese factory with a history of poor quality controls, or face shortages of treatments for American cancer patients.

Six months earlier, visiting Food and Drug Administration inspectors had uncovered what the agency later called “broad data manipulation” at the...

Facing Cancer Drug Shortage, U.S. Relies on Banned Chinese Plant Continue reading…

FDA investigates reported adverse events with WEN hair cleansing products

The FDA has announced it is investigating reports of adverse reactions, including hair loss, hair breakage, balding, itching and rash, associated with the use of WEN by Chas Dean Cleansing Conditioner products.

As of July 7, the agency had received 127 adverse event reports from consumers about the products, which is “the largest number of...

FDA investigates reported adverse events with WEN hair cleansing products Continue reading…

Mercedes, Ferrari Among Companies Selling Cars with Faulty Airbags

According to a U.S. Senate report released this week, Mercedes-Benz and Ferrari are selling vehicles equipped with faulty Takata airbags. And while it’s perfectly legal, safety advocates have criticized the automakers for not replacing the airbags before selling the cars.

Read More

Court: Ignition-switch lawsuits against GM can proceed

General Motors cannot avoid lawsuits from pre-bankruptcy ignition-switch defect victims, a federal court ruled Wednesday.

The U.S. Second Circuit Court of Appeals overturned a bankruptcy judge's ruling that had protected GM from those lawsuits because of the company's 2009 bankruptcy restructuring.

Read More